drugset / Trial / NCT02840591

Ramelteon and Citicoline for Delirium

NCT02840591

Non-randomizedParallel-groupOpen-labelOther

Summary

Primary aim of this study is to assess the feasibility of conducting clinical research for delirium (confusion due to medical problems) at Clements University Hospital in Dallas, Texas. A secondary aim is to assess whether an FDA-approved sleeping aid called Ramelteon or an over-the-counter supplement called Citicoline are safe and beneficial in delirium.

Timeline

Start
2016-07
Primary completion
2017-11
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Citicoline Other / unclassified 500 mg
Subject Ramelteon Unknown 8 mg

Indications